Effect of Adipocyte Secretome in Melanoma Progression and Vasculogenic Mimicry

Journal of Cellular Biochemistry

Volumn 117, Issue 7, 2016, Pages 1697-1706

  Coelho, Pedro ^a,b,c   Almeida, Joana ^b,c   Prudêncio, Cristina ^b,c   Fernandes, Rúben ^b,c   Soares, Raquel ^a,c  

^a University of Porto   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

ADIPOSE TISSUE; MELANOMA; OBESITY; VASCULOGENIC MIMICRY

Indexed keywords

ADIPONECTIN; COLONY STIMULATING FACTOR 1; FIBROBLAST GROWTH FACTOR 21; INTERLEUKIN 11; INTERLEUKIN 6; LEPTIN; LEUKEMIA INHIBITORY FACTOR; MELANIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOME; RESISTIN; RETINOL BINDING PROTEIN 4; SCATTER FACTOR; SECRETOME; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

3T3 CELL LINE; ADIPOCYTE; ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOLOGICAL MIMICRY; CANCER GROWTH; CELL ADHESION; CELL DEDIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SPREADING; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONDITIONED MEDIUM; CONTROLLED STUDY; CUTANEOUS MELANOMA; EX VIVO STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAABDOMINAL FAT; MELANOCYTE; MELANOMA B16; MELANOMA CELL LINE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SUBCUTANEOUS FAT; 3T3-L1 CELL LINE; ANIMAL; COMPLICATION; GENETICS; MELANOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OBESITY; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; INTRA-ABDOMINAL FAT; MELANOCYTES; MELANOMA; MICE; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; SUBCUTANEOUS FAT;

EID: 84954338719     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25463     Document Type: Article

References (62)

1. Ali AT, Hochfeld WE, Myburgh R, Pepper MS,. 2013. Adipocyte and adipogenesis. Eur J Cell Biol 92: 229-236.
2. Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN,. 2008. Obesity prevalence from a European perspective: A systematic review. BMC Public Health 8: 200.
3. Brandon EL, Gu JW, Cantwell L, He Z, Wallace G, Hall JE,. 2009. Obesity promotes melanoma tumor growth: Role of leptin. Cancer Biol Ther 8: 1871-1879.
4. Brychtova S, Bezdekova M, Hirnak J, Sedlakova E, Tichy M, Brychta T,. 2011. Stromal microenvironment alterations in malignant melanoma. In:, Murph M, editor. Research on melanoma-A glimpse into current directions and future trends. Czech Republic: InTech.
5. Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q,. 2013. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis. Eur J Cancer 49: 3914-3923.
6. Chen J, Chi M, Chen C, Zhang XD,. 2013. Obesity and melanoma: Exploring molecular links. J Cell Biochem 114: 1955-1961.
7. Chiang AC, Massagué J,. 2008. Molecular basis of metastasis. N Engl J Med 359: 2814-2823.
8. Chung HJ, Mahalingam M,. 2014. Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma-Implications for therapeutic strategies and targeted therapies. Expert Rev Anticancer Ther 14: 621-639.
9. Costa C, Incio J, Soares R,. 2007. Angiogenesis and chronic inflammation: Cause or consequence ? Angiogenesis 10: 149-166.
10. Dennis LK, Lowe JB, Lynch CF, Alavanja MCR,. 2008. Cutaneous melanoma and obesity in the agricultural health study. Ann Epidemiol 18: 214-221.
11. Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S,. 2012. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. PLoS ONE 7: e40378.
12. Fidler IJ,. 2003. The pathogenesis of cancer metastasis: The "seed and soil" hypothesis revisited. Nat Rev Cancer 3: 453-458.
13. Foty R,. 2011. A simple hanging drop cell culture protocol for generation of 3D spheroids. J Vis Exp 2720.
14. Frank NY, Schatton T, Kim S, Zhan Q, Wilson BJ, Ma J, Saab KR, Osherov V, Widlund HR, Gasser M, Waaga-Gasser AM, Kupper TS, Murphy GF, Frank MH,. 2011. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 71: 1474-1485.
15. Fridman WH, Pagès F, Sautès-Fridman C, Galon J,. 2012. The immune contexture in human tumours: Impact on clinical outcome. Nat Rev Cancer 12: 298-306.
16. Friedl P, Alexander S,. 2011. Cancer invasion and the microenvironment: Plasticity and reciprocity. Cell 147: 992-1009.
17. Friedl P, Wolf K,. 2003. Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 3: 362-374.
18. Garbe C, Leiter U,. 2009. Melanoma epidemiology and trends. Clin Dermatol 27: 3-9.
19. Green H, Kehinde O,. 1975. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5: 19-27.
20. Haffner S, Taegtmeyer H,. 2003. Epidemic obesity and the metabolic syndrome. Circulation 108: 1541-1545.
21. Hanahan D, Coussens LM,. 2012. Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 21: 309-322.
22. Hanahan D, Weinberg RA,. 2011. Hallmarks of cancer: The next generation. Cell 144: 646-674.
23. Hendrix MJC, Seftor EA, Hess AR, Seftor REB,. 2003. Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nat Rev Cancer 3: 411-421.
24. Hoashi T, Kadono T, Kikuchi K, Etoh T, Tamaki K,. 2001. Differential growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2. Biochem Biophys Res Commun 288: 371-379.
25. Humphries M,. 2001. Cell adhesion assays. Mol Biotechnol 18: 57-61.
26. Ibrahim MM,. 2010. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev 11: 11-18.
27. Jimbow K, Lee SK, King MG, Hara H, Chen H, Dakour J, Marusyk H,. 1993. Melanin pigments and melanosomal proteins as differentiation markers unique to normal and neoplastic melanocytes. J Invest Dermatol 100: 259S-268S.
28. Jung JI, Cho HJ, Jung YJ, Kwon S-H, Her S, Choi SS, Shin S-H, Lee KW, Park JHY,. 2015. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: Roles of adipocytes and M2-macrophages. Int J Cancer 136: 258-270.
29. Kleinman HK, Martin GR,. 2005. Matrigel: Basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386.
30. Kotobuki Y, Tanemura A, Yang L, Itoi S, Wataya-Kaneda M, Murota H, Fujimoto M, Serada S, Naka T, Katayama I,. 2012. Dysregulation of melanocyte function by Th17-related cytokines: Significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res 25: 219-230.
31. Lázár-Molnár E, Hegyesi H, Tóth S, Falus A,. 2000. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12: 547-554.
32. Lirdprapamongkol K, Chiablaem K, Sila-Asna M, Surarit R, Bunyaratvej A, Svasti J,. 2012. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 422: 429-435.
33. Loges S, Schmidt T, Carmeliet P,. 2010. Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates. Genes Cancer 1: 12-25.
34. Malvi P, Chaube B, Pandey V, Vijayakumar MV, Boreddy PR, Mohammad N, Singh SV, Bhat MK,. 2015. Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: Role of adipokines. Mol Oncol 9: 689-703.
35. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ,. 1999. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol 155: 739-752.
36. Marks R,. 2000. Epidemiology of melanoma. Clin Exp Dermatol 25: 459-463.
37. Matano F, Yoshida D, Ishii Y, Tahara S, Teramoto A, Morita A,. 2014. Endocan, a new invasion and angiogenesis marker of pituitary adenomas. J Neurooncol 117: 485-491.
38. Meeran SM, Singh T, Nagy TR, Katiyar SK,. 2009. High-fat diet exacerbates inflammation and cell survival signals in the skin of ultraviolet B-irradiated C57BL/6 mice. Toxicol Appl Pharmacol 241: 303-310.
39. Mendonça F, Soares R,. 2015. Obesity and cancer phenotype: Is angiogenesis a missed link ? Life Sci 139: 16-23.
40. Mendonça FM, de Sousa FR, Barbosa AL, Martins SC, Araújo RL, Soares R, Abreu C,. 2015. Metabolic syndrome and risk of cancer: Which link ? Metabolism 64: 182-189.
41. Monteiro R,. 2009. Chronic inflammation in the metabolic syndrome: Emphasis on adipose tissue. In:, Soares R, Costa C, editors. Oxidative stress, inflammation and angiogenesis in the metabolic syndrome. Springer Netherlands: Dordrecht.
42. Morpurgo G, Fioretti B, Catacuzzeno L,. 2012. The increased incidence of malignant melanoma in obese individuals is due to impaired melanogenesis and melanocyte DNA repair. Med Hypotheses 78: 533-535.
43. Nagel G, Bjørge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Häggström C, Engeland A, Johansen D, Kleiner A, Selmer R, Ulmer H, Tretli S, Jonsson H, Concin H, Stattin P, Lukanova A,. 2012. Metabolic risk factors and skin cancer in the metabolic syndrome and cancer project (Me-Can). Br J Dermatol 167: 59-67.
44. Naspi A, Panasiti V, Abbate F, Roberti V, Devirgiliis V, Curzio M, Borghi M, Lozupone F, Carotti S, Morini S, Gaudio E, Calvieri S, Londei P,. 2014. Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo. PLoS ONE 9: e98641.
45. Neudauer CL, McCarthy JB,. 2003. Insulin-like growth factor I-stimulated melanoma cell migration requires phosphoinositide 3-kinase but not extracellular-regulated kinase activation. Exp Cell Res 286: 128-137.
46. Osawa T, Muramatsu M, Watanabe M, Shibuya M,. 2009. Hypoxia and low-nutrition double stress induces aggressiveness in a murine model of melanoma. Cancer Sci 100: 844-851.
47. Pandey V, Vijayakumar MV, Ajay AK, Malvi P, Bhat MK,. 2012. Diet-induced obesity increases melanoma progression: Involvement of Cav-1 and FASN. Int J Cancer 130: 497-508.
48. Parekh N, Chandran U, Bandera EV,. 2012. Obesity in Cancer Survival. Annu Rev Nutr 32: 311-342.
49. Pirraco A, Coelho P, Rocha A, Costa R, Vasques L, Soares R,. 2010. Imatinib targets PDGF signaling in melanoma and host smooth muscle neighboring cells. J Cell Biochem 111: 433-441.
50. Poulos SP, Dodson MV, Hausman GJ,. 2010. Cell line models for differentiation: Preadipocytes and adipocytes. Exp Biol Med (Maywood) 235: 1185-1193.
51. Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Dano K, Ruiter DJ, Verheijen JH,. 1991. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 115: 191-199.
52. Ribatti D, Nico B, Cimpean AM, Raica M, Crivellato E, Ruggieri S, Vacca A,. 2013. B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry. Clin Exp Med 13: 143-147.
53. Rubenstein AH,. 2005. Obesity: A modern epidemic. Trans Am Clin Climatol Assoc 116: 103-111.
54. Sergentanis TN, Antoniadis AG, Gogas HJ, Antonopoulos CN, Adami HO, Ekbom A, Petridou ET,. 2013. Obesity and risk of malignant melanoma: A meta-analysis of cohort and case-control studies. Eur J Cancer 49: 642-657.
55. Taubes G,. 2012. Unraveling the obesity-cancer connection. Science 335: 28-32.
56. Thiery JP,. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
57. Thies A, Mangold U, Moll I, Schumacher U,. 2001. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol 195: 537-542.
58. Tuong W, Cheng LS, Armstrong AW,. 2012. Melanoma: Epidemiology, diagnosis, treatment, and outcomes. Dermatol Clin 30: 113-124.
59. van der Schaft DWJ, Seftor REB, Seftor E a, Hess AR, Gruman LM, Kirschmann D a, Yokoyama Y, Griffioen AW, Hendrix MJC,. 2004. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 96: 1473-1477.
60. Vucenik I, Stains JP,. 2012. Obesity and cancer risk: Evidence, mechanisms, and recommendations. Ann N Y Acad Sci 1271: 37-43.
61. Wagner M, Bjerkvig R, Wiig H, Melero-Martin JM, Lin R-Z, Klagsbrun M, Dudley AC,. 2012. Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis 15: 481-495.
62. Zhao W, Liu H, Xu S, Entschladen F, Niggemann B, Zänker KS, Han R,. 2001. Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett 162: 49-55.